仭擼庮釃偵懳偡傞擼methionine PET

丂懱姴晹偺庮釃偺専弌偵娭偟偰偼丄18F-FDG-PET偼偡偱偵堦掕偺昡壙偑妋棫偟偰偄傞偑丄擼庮釃偵娭偟偰偼偙傟偩偗偱偼恌抐偑崲擄側徢椺偑懡偄丅擼庮釃傕懠偺埆惈庮釃偲摨條偵埆惈搙偲FDG廤愊偼憡娭偡傞偙偲偑傢偐偭偰偄傞偑丄擼偼傕偲傕偲摐戙幱偑妶敪偱偁傞偨傔丄惓忢偱傕FDG偼崅搙偵廤愊偡傞丅廬偭偰庮釃晹暘偑昁偢偟傕梲惈昤夋偱偒傞偲偼尷傜偢丄傓偟傠廃埻偺惓忢慻怐偵斾傋偰掅廤愊偲偟偰昤弌偝傟傞偙偲傕偁傞丅 奜壢揑揈彍傗曻幩慄帯椕偺寁夋傪偡傞嵺偺庮釃嫬奅偺敾掕傪栚揑偲偟偨応崌丄18F-FDG偼恌抐惛搙偵偍偄偰11C-methionine偵柧傜偐偵楎傞丅methionine偼廤愊婡彉偲偟偰丄傾儈僲巁僩儔儞僗億乕僞乕偵傛傝寣塼擼娭栧傪捠夁偟丄抈敀崌惉偵傛傝庮釃嵶朎偺堦晹偲偟偰庢傝崬傑傟傞傕偺偲偝傟偰偍傝丄傾儈僲巁戙幱偺巜昗偲側傞丅堦斒偵惓忢擼慻怐偼傾儈僲巁戙幱偑掅偄偨傔丄庮釃嵶朎傊偺廤愊偺僐儞僩儔僗僩偼旕忢偵椙偄丅傑偨偙傟傑偱偺曬崘偱傕methionine偺廤愊斖埻偼丄FDG偺廤愊傗MRI, CT偺憿塭斖埻傛傝傕峀斖偱偁傝丄庮釃偺斖埻傪揔愗偵昡壙偟偰偄傞偲偝傟偰偄傞1)丅偙傟傑偱FDG偼慻怐妛揑埆惈搙偺恌抐偵桳梡偱丄methionine偼庮釃偺懚嵼斖埻恌抐偵桳岠偱偁傞偲偄偆峫偊偑懡偐偭偨偑丄Kato傜偼methionine偺廤愊傕丄glioma偺惗暔妛揑憹怋擻偺巜昗偱偁傞MIB-1 index偲偺娫偵傕惓偺憡娭偑偁傞偙偲傪帵偟偨2)丅廬偭偰埆惈搙偺恌抐偵傕桳梡偱偁傞偙偲偑傢偐偭偰偄傞丅埲忋偺偙偲傛傝擼庮釃恌抐偺椪彴柺偱摿偵墳梡偑婜懸偝傟傞妀庬偱偁傞丅 偟偐偟11C偺暔棟妛揑敿尭婜偼栺20暘偱偁傝丄僒僀僋儘僩儘儞偺暪愝偑昁恵偱偁傝丄巤峴偱偒傞専嵏悢傕尷奅偑偁傞丅傑偨墷暷偱偼曐尟揔墳偵側偭偰偄傞崙偑懡偄偑丄尰帪揰偱偼杮朚偺曐尟揔墳偱偼側偔丄尷傜傟偨巤愝偱偺専嵏偲側偭偰偄傞丅

仭fig. 1

擼庮釃偺FDG-PET夋憸
偗偄傟傫丄堄幆忈奞偵偰敪徢偟偨70嵨戙彈惈丅恄宱妛揑強尒偲偟偰尒摉幆忈奞丄偍傛傃塣摦惈幐岅偑傒傜傟偨丅MMSE23揰丅MRI偱偼嵍懁摢梩撪懁柺乣屻摢梩撪懁柺偵愯嫆惈昦曄傪擣傔偨丅擼FDG-PET偱偼MRI忋偺堎忢怣崋堟偺晹埵偵廤愊偺憹壛傪擣傔傞丅忋抜偼姤忬抐憸丄壓抜偼悈暯抐憸丅

仭fig. 2

擼庮釃偺MET-PET夋憸
擼MET-PET夋憸偱偼丄FDG偱傕傒傜傟偨堎忢廤愊晹埵偵堦抳偟偰丄傛傝尠挊側RI庢傝崬傒傪擣傔傞丅

• 1) Laere KV et al. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma : sensitivity inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32(1) : 39-51, 2005
• 2) Kato T, Shinoda J, Nakayama N., et al. Metabolic Assessment of Gliomas Using 11C-Methionine, 18F-FDG, and 11C-Choline Positron-Emission Tomography. AJNR 29. 1432-1437. 2008

仸偙偺専嵏偵偮偄偰偺偍栤偄崌傢偣偼丄03-3353-8111 撪慄 21010 妀堛妛丒PET専嵏幒傑偱丅

仸偙偺専嵏偺姵幰梡愢柧彂偼丄偙偪傜乮PDF 2儁乕僕乯傪偛棙梡壓偝偄丅

仾偙偺儁乕僕偺僩僢僾偵栠傞